HIGHER SUSTAINED VIROLOGIC RESPONSE RATE IN FEMALE THAN MALE HEPATITIS C VIRUS PATIENTS TREATED WITH DIRECT-ACTING ANTIVIRALS AT AN URBAN ACADEMIC MEDICAL CENTER

被引：0
|
作者：
Martin, Michelle [1 ,2 ]
Nabulsi, Nadia [3 ]
Lee, Todd [3 ]
Koppe, Sean [2 ,4 ]
机构：
[1] Univ Illinois, Coll Pharm, Pharm Practice, Chicago, IL USA
[2] Univ Illinois Hosp & Hlth Sci Syst, Chicago, IL USA
[3] Univ Illinois, Coll Pharm, Pharm Syst, Outcomes & Policy, Chicago, IL USA
[4] Univ Illinois, Coll Med, Hepatol, Chicago, IL USA
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1539
引用
收藏
页码：926A / 927A
页数：2
相关论文
共 50 条
  • [31] The risk of hepatitis C virus recurrence in hepatitis C virus-infected patients treated with direct-acting antivirals after achieving a sustained virological response: A comprehensive analysis
    Huang, Peng
    Wang, Yan
    Yue, Ming
    Ge, Zhijun
    Xia, Xueshan
    Jeyarajan, Andre J.
    Holmes, Jacinta A.
    Yu, Rongbin
    Zhu, Chuanwu
    Yang, Sheng
    Lin, Wenyu
    Chung, Raymond T.
    LIVER INTERNATIONAL, 2021, 41 (10) : 2341 - 2357
  • [32] Extrahepatic Cancer Risk in Patients with Hepatitis C Virus Infection Treated with Direct-Acting Antivirals
    Tani, Joji
    Masaki, Tsutomu
    Oura, Kyoko
    Tadokoro, Tomoko
    Morishita, Asahiro
    Kobara, Hideki
    MICROORGANISMS, 2024, 12 (09)
  • [33] Long-term changes in liver elasticity in hepatitis C virus-infected patients with sustained virologic response after treatment with direct-acting antivirals
    Pietsch, Veronika
    Deterding, Katja
    Attia, Dina
    Ringe, Kristina Imeen
    Heidrich, Benjamin
    Cornberg, Markus
    Gebel, Michael
    Manns, Michael Peter
    Wedemeyer, Heiner
    Potthoff, Andrej
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2018, 6 (08) : 1188 - 1198
  • [34] Noninvasive diagnosis of fibrosis in the patients with hepatitis C virus infection treated with direct-acting antivirals
    Numao, H.
    Shimaya, K.
    Hasui, K.
    Igarashi, K.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S547 - S547
  • [35] Hepatitis C virus core antigen in the management of patients treated with new direct-acting antivirals
    Alados Arboledas, Juan Carlos
    Pavon Guerrero, Inmaculada
    Blanco Rodriguez, Maria Jose
    Torres Martos, Eva
    Belen Perez, Ana
    Cepero Leon, Cristina
    Sierra Sanchez, Jesus F.
    Lopez Prieto, Maria Dolores
    Chueca Porcuna, Natalia
    Ocete Mochon, Maria Dolores
    Macias, Juan
    de la Iglesia Salgado, Alberto
    Rodriguez Granger, Javier
    Delgado Fernandez, Marcial
    Guerrero Lozano, Inmaculada
    Reigadas Ramirez, Elena
    Rivero, Antonio
    Lozano Dominguez, Maria del Carmen
    Viciana, Isabel
    Galan Montemayor, Juan Carlos
    Garcia Garcia, Federico
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2017, 89 (01) : 29 - 34
  • [36] Evaluation of patients with virus C hepatitis treated with direct-acting antivirals in the Chilean public system
    Mezzano, Gabriel
    Aguirre, Herman
    Pena, Andrea
    Gomez, Fernando
    Nazal, Leyla
    Pablo Arab, Juan
    Pablo Roblero, Juan
    REVISTA MEDICA DE CHILE, 2021, 149 (12) : 1687 - 1693
  • [37] Changes in the lipid profile in hepatitis C virus infected patients treated with direct-acting antivirals
    Monteserin, L.
    Quinones, R.
    Molina, G.
    Guerra, M.
    Fernandez-Moran, E.
    Jimenez, M.
    Reyes, N.
    Alvarez-Cuenllas, B.
    Linares, P.
    Vivas, S.
    Gutierrez, E.
    Jorquera, F.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S729 - S729
  • [38] Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir
    Karino, Yoshiyasu
    Toyota, Joji
    Ikeda, Kenji
    Suzuki, Fumitaka
    Chayama, Kazuaki
    Kawakami, Yoshiiku
    Ishikawa, Hiroki
    Watanabe, Hideaki
    Hernandez, Dennis
    Yu, Fei
    McPhee, Fiona
    Kumada, Hiromitsu
    JOURNAL OF HEPATOLOGY, 2013, 58 (04) : 646 - 654
  • [39] Efficacy of hepatitis B virus vaccination in genotype 4 chronic hepatitis C patients achieved sustained virologic response with direct acting antivirals
    Hassany, M.
    Aziz, H. A.
    Rahman, T. A.
    Eysa, B.
    El-Sayed, M. H.
    Samir, A.
    Hassan, M.
    Elshafie, A.
    Asem, N.
    Ibrahem, M.
    Esmat, G.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 : 182 - 183
  • [40] Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C
    Ioanna Aggeletopoulou
    Christos Konstantakis
    Spilios Manolakopoulos
    Christos Triantos
    World Journal of Gastroenterology, 2017, (24) : 4317 - 4323
12345